Profile data is unavailable for this security.
About the company
Shanghai MicuRx Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development (R&D) and commercialization of innovative drugs. The Company's antibacterial drug product, contezolid tablets, can be applied to treat infections caused by multidrug-resistant gram-positive bacteria. The Company also has a number of new anti-drug-resistant bacteria, kidney cancer, nephritis drugs and anti-new crown drug pipelines in the preclinical stage, including MRX-4, MRX-5, MRX-7, MRX-15, MRX-17 and others. The Company operates its businesses primarily in the domestic market.
- Revenue in CNY (TTM)109.40m
- Net income in CNY-497.31m
- Incorporated2012
- Employees205.00
- LocationShanghai MicuRx Pharmaceutical Co LtdSHANGHAI 201210ChinaCHN
- Phone+86 2 150900550
- Fax+86 2 161101898
- Websitehttp://www.micurxchina.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jiangsu Lianhuan Pharmaceutical Co. Ltd | 2.35bn | 136.37m | 2.30bn | 1.30k | 16.89 | 1.68 | -- | 0.982 | 0.4777 | 0.4777 | 8.22 | 4.81 | 0.8255 | 3.44 | 4.60 | 1,810,024.00 | 5.50 | 5.93 | 11.40 | 11.25 | 48.56 | 53.26 | 6.66 | 7.82 | 0.7093 | 6.96 | 0.3522 | 30.64 | 11.20 | 16.36 | -4.50 | 12.91 | 9.35 | 13.97 |
Zhejiang Shapuaisi Pharmaceutical Co Ltd | 540.27m | -72.66m | 2.37bn | 1.39k | -- | 1.40 | -- | 4.39 | -0.1922 | -0.1922 | 1.44 | 4.46 | 0.2581 | 2.94 | 13.86 | 390,086.00 | -3.48 | -0.7573 | -4.00 | -0.8713 | 51.90 | 58.02 | -13.49 | -2.45 | 0.8094 | -- | 0.1284 | -- | 17.37 | 1.21 | -43.23 | -- | 30.36 | -- |
Shanghai MicuRx Pharmaceutical Co Ltd | 109.40m | -497.31m | 2.43bn | 205.00 | -- | 3.71 | -- | 22.22 | -0.759 | -0.759 | 0.167 | 0.9991 | 0.0919 | 0.5886 | 5.18 | 533,680.30 | -41.76 | -- | -45.09 | -- | 81.44 | -- | -454.56 | -- | 7.87 | -- | 0.2914 | -- | 88.31 | -- | -91.16 | -- | -- | -- |
GuiZhou YiBai Pharmaceutical Co., Ltd. | 2.51bn | -131.00m | 2.45bn | 5.51k | -- | 0.8978 | -- | 0.9753 | -0.1654 | -0.1654 | 3.17 | 3.44 | 0.5335 | 1.48 | 10.54 | 455,445.80 | -3.01 | 0.8648 | -4.09 | 1.18 | 63.72 | 74.87 | -5.63 | 1.45 | 1.26 | -3.93 | 0.2515 | 216.36 | 3.12 | -6.19 | 124.25 | -- | -16.51 | -- |
Henan Taloph Pharmaceutical Stock Co Ltd | 2.00bn | 108.51m | 2.48bn | 2.35k | 23.26 | 1.58 | -- | 1.24 | 0.1857 | 0.1857 | 3.47 | 2.73 | 0.572 | 3.01 | 2.11 | 851,358.90 | 3.25 | 0.272 | 7.08 | 0.4981 | 28.52 | 27.97 | 5.68 | 0.5501 | 0.81 | 2.99 | 0.4312 | 28.70 | 5.57 | 11.62 | 160.32 | -- | -8.27 | -- |
Obio Technology Shanghai Corp Ltd | 234.12m | -196.49m | 2.53bn | 731.00 | -- | 1.30 | -- | 10.81 | -0.3052 | -0.3052 | 0.3624 | 3.00 | 0.0938 | 3.61 | 2.37 | 320,267.70 | -7.88 | 0.2246 | -8.68 | 0.2514 | -19.93 | 36.72 | -84.03 | 1.48 | 2.14 | -- | 0.1128 | 0.00 | -29.69 | 35.88 | -425.90 | -- | 57.00 | -- |
Data as of Sep 20 2024. Currency figures normalised to Shanghai MicuRx Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 13.89m | 4.02% |
Golden Trust Sinopac Fund Management Co., Ltd.as of 31 Dec 2023 | 3.23m | 0.94% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 2.25m | 0.65% |
Gfund Management Co., Ltd.as of 31 Dec 2023 | 1.89m | 0.55% |
Huatai-PineBridge Fund Management Co., Ltd.as of 31 Dec 2023 | 500.40k | 0.15% |
Manulife TEDA Fund Management Co., Ltd.as of 31 Dec 2023 | 463.13k | 0.13% |
Orient Securities Asset Management Co. Ltd.as of 31 Dec 2023 | 449.10k | 0.13% |
Harvest Fund Management Co., Ltd.as of 31 Dec 2023 | 295.58k | 0.09% |
Hongde Fund Management Co., Ltd.as of 31 Dec 2023 | 292.30k | 0.09% |
CPIC Fund Management Co. Ltd.as of 31 Dec 2023 | 276.79k | 0.08% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.